Wipro, BPCL, Paytm, Aurobindo Pharma: Stocks to watch on Monday

Stocks to watch on Monday, April 8: At around 8:06 am, Gift Nifty futures traded with a gain of 0.26 per cent, or 58.5 points, at 22,654, suggesting a positive opening on the D-Street.

The equity benchmark index Sensex registered marginal gains to hit a fresh lifetime high on Friday after the Reserve Bank of India (RBI) maintained the status quo on key interest rates amid a negative trend in global markets. The 30-share BSE Sensex inched up 20.59 points, or 0.03 per cent, to settle at a fresh record closing high of 74,248.22. 

The broader NSE Nifty ended with a marginal loss of 0.95 points at 22,513.70. As many as 28 components of the 50-share benchmark ended in red.

Here are some stocks that will be in focus on Monday, April 8.

Wipro: The company informed exchanges about the exit of CEO Thierry Delaporte, who, after a significant tenure at the company, will be replaced by the new Srini Pallia, appointed as the Chief Executive Officer and Managing Director of the company, effective immediately.

Nykaa: The fashion e-retailer posted strong GMV growth in the early thirties on a consolidated basis year-on-year during the recently concluded quarter.

BPCL: The company recorded the highest-ever market sales of 50.95 MMT during the years 2023–24.

Godrej Consumer Products: The company said it expects to deliver underlying volume growth of high single digits and sales growth of mid-single digits, driven largely by currency volatility at a consolidated level (organic). 

Paytm: Paytm parent One97 Communication approves a grant of 91,250 stock options. 

Aurobindo Pharma: The United States Food and Drug Administration (USFDA) inspected a new injectable facility of Eugia Steriles Private Limited, situated in Andhra Pradesh. The inspection closed with three observations.

GE Power: The company received a purchase order worth Rs 10.1 crore from Mangalore Refinery and Petrochemicals Limited.

Titan: The company posted good growth in revenue of 17 per cent YoY, with CaratLane leading the company's growth at 30 per cent sales growth. 

Tata Steel: The company said in its Q4 business update that production at the company soared a tad 1.7 per cent during the March quarter of FY24.

Voltas: In the previous fiscal year, volume at the company logged a healthy growth of 35 per cent on year amid a good quantum of sales of AC units. This is a magnificent milestone achieved by the company, as no consumer durable company in any fiscal year has logged such huge sales.

Nestle India: There has been approval to increase royalty payments to the company's Swiss parent, Société des Produits Nestlé S.A. Nestlé S.A., in the next five years, will increase its payout to 5.25% from the current 4.5% per annum.

GCPL: The FMCG company, in its Q4 business update, said that on a consolidated level, the company posted high single-digit growth in volume during the period. The company's Indonesian business is logging double-digit growth in volume and revenue.

Aurobindo Pharma: The US FDA has inspected the company's subsidiary and issued three observations post-conclusion of the investigation.

Strides Pharma: At the company's subsidiary's formulation facility, the USFDA, after a regular GMP exercise, has issued two observations.

InfoEdge: The company has released an update for the standalone billing, which during the last March-ended quarter registered 10.5 per cent on-year growth to Rs 826.9 crore.

Chola Investment: The disbursement at the NBFC company logged high double-digit growth during the March-ended quarter. AUM at the company has also logged a good 55 per cent jump. 

PNB: In its Q4 business update, the bank informed that advances at the company grew 11.5 per cent on year, while deposits grew 7 per cent on year.

Bank of Baroda: At the lender, retail advances during Q4, posted a healthy on-year growth of 20.64 per cent. 

(With inputs from agencies.) 

Catch the latest stock market updates here. For all other news related to business, politics, tech and auto, visit Zeebiz.com.